TLIS
Talis Biomedical Corporation Common Stock
TLIS
TLIS
Delisted
TLIS was delisted on the 30th of August, 2024.
22 hedge funds and large institutions have $5.27M invested in Talis Biomedical Corporation Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
22
Holding in Top 10
–
Calls
$13K
Puts
–
Top Buyers
| 1 | +$23.5K | |
| 2 | +$18.7K | |
| 3 | +$5.88K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.03K |
| 5 |
Morgan Stanley
New York
|
+$482 |
Top Sellers
| 1 | -$235K | |
| 2 | -$110K | |
| 3 | -$39K | |
| 4 |
Millennium Management
New York
|
-$34.7K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7.11K |